• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCG 疫苗接种不能预防 SARS-CoV-2,这一结论得到了流行病学分析的支持。

Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.

机构信息

Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Sci Rep. 2020 Oct 27;10(1):18377. doi: 10.1038/s41598-020-75491-x.

DOI:10.1038/s41598-020-75491-x
PMID:33110184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7591473/
Abstract

The Bacillus Calmette-Guerin (BCG) vaccine provides protection against tuberculosis (TB), and is thought to provide protection against non-TB infectious diseases. BCG vaccination has recently been proposed as a strategy to prevent infection with SARS-CoV-2 (CoV-2) to combat the COVID-19 outbreak, supported by its potential to boost innate immunity and initial epidemiological analyses which observed reduced severity of COVID-19 in countries with universal BCG vaccination policies. Seventeen clinical trials are currently registered to inform on the benefits of BCG vaccinations upon exposure to CoV-2. Numerous epidemiological analyses showed a correlation between incidence of COVID-19 and BCG vaccination policies. These studies were not systematically corrected for confounding variables. We observed that after correction for confounding variables, most notably testing rates, there was no association between BCG vaccination policy and COVD-19 spread rate or percent mortality. Moreover, we found variables describing co-morbidities, including cardiovascular death rate and smoking prevalence, were significantly associated COVID-19 spread rate and percent mortality, respectively. While reporting biases may confound our observations, our epidemiological findings do not provide evidence to correlate overall BCG vaccination policy with the spread of CoV-2 and its associated mortality.

摘要

卡介苗(BCG)疫苗可预防结核病(TB),并被认为可预防非结核病传染病。BCG 疫苗接种最近被提议作为预防 SARS-CoV-2(CoV-2)感染的策略,以应对 COVID-19 疫情,这一策略得到了其增强先天免疫的潜力以及最初的流行病学分析的支持,这些分析观察到在普遍实施 BCG 疫苗接种政策的国家,COVID-19 的严重程度降低。目前有 17 项临床试验注册,以了解接触 CoV-2 时 BCG 疫苗接种的益处。许多流行病学分析显示 COVID-19 的发病率与 BCG 疫苗接种政策之间存在相关性。这些研究没有系统地校正混杂变量。我们观察到,在对混杂变量(尤其是检测率)进行校正后,BCG 疫苗接种政策与 COVD-19 传播率或死亡率百分比之间没有关联。此外,我们发现描述合并症的变量,包括心血管死亡率和吸烟率,分别与 COVID-19 传播率和死亡率百分比显著相关。虽然报告偏倚可能会影响我们的观察结果,但我们的流行病学发现并未提供证据表明总体 BCG 疫苗接种政策与 CoV-2 的传播及其相关死亡率之间存在相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ea/7591473/05e4121ee452/41598_2020_75491_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ea/7591473/066294162d47/41598_2020_75491_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ea/7591473/ff91f2fbc61c/41598_2020_75491_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ea/7591473/05e4121ee452/41598_2020_75491_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ea/7591473/066294162d47/41598_2020_75491_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ea/7591473/ff91f2fbc61c/41598_2020_75491_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ea/7591473/05e4121ee452/41598_2020_75491_Fig3_HTML.jpg

相似文献

1
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.BCG 疫苗接种不能预防 SARS-CoV-2,这一结论得到了流行病学分析的支持。
Sci Rep. 2020 Oct 27;10(1):18377. doi: 10.1038/s41598-020-75491-x.
2
Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.卡介苗(BCG)接种在 COVID-19 大流行死亡率中的潜在作用:流行病学和免疫学方面。
Asian Pac J Allergy Immunol. 2020 Sep;38(3):150-161. doi: 10.12932/AP-310520-0863.
3
The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.卡介苗(BCG)接种对COVID-19发病率和死亡率的影响——文献综述
Przegl Epidemiol. 2020;74(2):290-302. doi: 10.32394/pe.74.22.
4
BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?卡介苗能否成为预防新冠疫情感染及严重程度的变革性手段?
Allergol Immunopathol (Madr). 2020 Sep-Oct;48(5):507-517. doi: 10.1016/j.aller.2020.05.002. Epub 2020 Jul 3.
5
Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.多剂量卡介苗可避免糖尿病患者出现新冠并发症:β细胞再生的病例研究
Pharmazie. 2020 Aug 1;75(8):375-380. doi: 10.1691/ph.2020.0494.
6
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.在新冠疫情期间使用卡介苗增强医护人员的非特异性防护:丹麦一项随机对照试验研究方案的结构化总结
Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.
7
The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.卡介苗(BCG)接种预防除结核病以外的严重传染性呼吸道疾病的效果:对 COVID-19 大流行的影响。
Vaccine. 2020 Sep 22;38(41):6374-6380. doi: 10.1016/j.vaccine.2020.08.018. Epub 2020 Aug 10.
8
BCG epidemiology supports its protection against COVID-19? A word of caution.BCG 的流行病学数据支持其对 COVID-19 的保护作用吗?谨慎看待。
PLoS One. 2020 Oct 7;15(10):e0240203. doi: 10.1371/journal.pone.0240203. eCollection 2020.
9
Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).别再摆弄数据了:目前没有可靠证据表明卡介苗能预防新型冠状病毒感染。
Acta Biomed. 2020 May 11;91(2):207-213. doi: 10.23750/abm.v91i2.9700.
10
[Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].[卡介苗对预防新型冠状病毒感染可能的作用进展:最新情况]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Nov;36(11):1044-1048.

引用本文的文献

1
Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study.墨西哥南部大学生中针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域和核衣壳的IgG抗体检测:一项横断面研究。
BMC Infect Dis. 2024 Jun 12;24(1):584. doi: 10.1186/s12879-024-09435-5.
2
Non-specific protection against severe COVID-19 associated to typhoid fever and DTP vaccination.针对与伤寒热和百白破疫苗接种相关的重症新冠病毒病的非特异性保护作用。
Heliyon. 2024 Apr 23;10(9):e29935. doi: 10.1016/j.heliyon.2024.e29935. eCollection 2024 May 15.
3

本文引用的文献

1
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly.激活:卡介苗疫苗接种预防老年人感染的随机临床试验。
Cell. 2020 Oct 15;183(2):315-323.e9. doi: 10.1016/j.cell.2020.08.051. Epub 2020 Sep 1.
2
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.追踪 SARS-CoV-2 刺突蛋白的变化:D614G 增加 COVID-19 病毒感染力的证据。
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
3
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
The gut microbe pair of sp. GMB0313 and sp. GMB0270 confers complete protection against SARS-CoV-2 infection by activating CD8+ T cell-mediated immunity.
该肠道微生物对 sp. GMB0313 和 sp. GMB0270 的组合通过激活 CD8+T 细胞介导的免疫,赋予了针对 SARS-CoV-2 感染的完全保护作用。
Gut Microbes. 2024 Jan-Dec;16(1):2342497. doi: 10.1080/19490976.2024.2342497. Epub 2024 Apr 18.
4
Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan.体液免疫和 T 细胞应答对 SARS-CoV-2 的反应揭示了在巴基斯坦大流行早期期间的免疫情况。
BMC Infect Dis. 2023 Dec 1;23(1):846. doi: 10.1186/s12879-023-08829-1.
5
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.BCG 疫苗接种通过适应性免疫反应的反馈刺激整合的器官免疫,从而产生持久的先天抗病毒抵抗力。
Nat Immunol. 2024 Jan;25(1):41-53. doi: 10.1038/s41590-023-01700-0. Epub 2023 Nov 30.
6
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.应对新冠疫情之外的大流行病的多维未来主义方法。
Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.
7
COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective.新型冠状病毒肺炎与早期大流行、脓毒症及疫苗:历史视角
J Intensive Med. 2021 May 18;1(1):4-13. doi: 10.1016/j.jointm.2021.04.003. eCollection 2021 Jul.
8
Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.口服表达新冠病毒核衣壳的通用细菌载体疫苗对仓鼠有效。
Microbiol Spectr. 2023 Mar 14;11(2):e0503522. doi: 10.1128/spectrum.05035-22.
9
Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial.评估卡介苗对非肌层浸润性膀胱癌患者中新型冠状病毒2的保护作用:一项多中心观察性试验。
Cancers (Basel). 2023 Mar 6;15(5):1618. doi: 10.3390/cancers15051618.
10
The COVID-19 pandemic in sub-Saharan Africa: The significance of presumed immune sufficiency.撒哈拉以南非洲的新冠疫情:假定免疫充足的意义。
Afr J Lab Med. 2023 Jan 30;12(1):1964. doi: 10.4102/ajlm.v12i1.1964. eCollection 2023.
BCG 疫苗可预防严重的 2019 年冠状病毒病(COVID-19)。
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726. doi: 10.1073/pnas.2008410117. Epub 2020 Jul 9.
4
Maximum Daily Temperature, Precipitation, Ultraviolet Light, and Rates of Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States.美国最高日温度、降水、紫外线与严重急性呼吸综合征冠状病毒 2 传播率
Clin Infect Dis. 2020 Dec 3;71(9):2482-2487. doi: 10.1093/cid/ciaa681.
5
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.ACE2 受体多态性:易感性、高血压、多器官衰竭与 COVID-19 疾病结局。
J Microbiol Immunol Infect. 2020 Jun;53(3):425-435. doi: 10.1016/j.jmii.2020.04.015. Epub 2020 May 6.
6
BCG-induced trained immunity: can it offer protection against COVID-19?BCG 诱导的训练免疫:能提供针对 COVID-19 的保护吗?
Nat Rev Immunol. 2020 Jun;20(6):335-337. doi: 10.1038/s41577-020-0337-y.
7
Considering BCG vaccination to reduce the impact of COVID-19.考虑接种卡介苗以减轻新型冠状病毒肺炎的影响。
Lancet. 2020 May 16;395(10236):1545-1546. doi: 10.1016/S0140-6736(20)31025-4. Epub 2020 Apr 30.
8
Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China.有效的遏制解释了近期中国确诊 COVID-19 病例呈次指数级增长的原因。
Science. 2020 May 15;368(6492):742-746. doi: 10.1126/science.abb4557. Epub 2020 Apr 8.
9
The Humoral Immune Response to BCG Vaccination.BCG 疫苗接种的体液免疫应答。
Front Immunol. 2019 Jun 11;10:1317. doi: 10.3389/fimmu.2019.01317. eCollection 2019.
10
Non-specific effects of BCG vaccine on viral infections.卡介苗疫苗对病毒感染的非特异性作用。
Clin Microbiol Infect. 2019 Dec;25(12):1473-1478. doi: 10.1016/j.cmi.2019.04.020. Epub 2019 May 2.